21 CFR 520.1660b
§ 520.1660b Oxytetracycline capsules.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 520.1660b, § 520.1660b Oxytetracycline capsules, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87257
- Permanent ID
ys:prov:87257@1- SHA-256
5d1fc7f48a8329f111b87999342a3d60decee76fa2d119dde4c8b4b35ff225b9
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each capsule contains 125 or 250 milligrams (mg) oxytetracycline hydrochloride.
(b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs and cats—(1) Amount. Administer orally 25 to 50 mg per pound of body weight per day in divided doses at 12-hour intervals.
(2) Indications for use. For the treatment of bacterial pneumonia caused by Brucella bronchiseptica, tonsilitis caused by Streptococcus hemolyticus, bacterial enteritis caused by Escherichia coli, urinary tract infections caused by Escherichia coli, and wound infections caused by Staphylococcus aureus.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.